Anju Harilal

A novel in vitro three-dimensional retinoblastoma model for evaluating chemotherapeutic drugs.

Moutushy Mitra, Chandana Mohanty, Anju Harilal et al. · PubMed · 2012 · 47 citations · Full text

EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapy.

Moutushy Mitra, Mallikarjuna Kandalam, Anju Harilal et al. · PubMed · 2012 · 32 citations · Full text

Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.

Moutushy Mitra, Ranjita Misra, Anju Harilal et al. · PubMed · 2011 · 23 citations · Full text

Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy

Moutushy Mitra, Fahima Dilnawaz, Ranjita Misra et al. · Cancer Nanotechnology · 2010 · 23 citations · Full text